Metastatic Breast Cancer (MBC) NewsLatest News On Metastatic Breast Cancer (MBC) Metronomic Capecitabine Plus Aromatase Inhibitor Boosts Survival in HR+ Breast Cancer1/10/2025 7:11 AM Cardiac Health Can Determine Breast Cancer Severity1/7/2025 11:46 PM Time for Standard Alert-Based PRO Monitoring in Breast Cancer12/16/2024 11:46 PM Brain Metastasis Screening in MBC: Navigating Challenges in Clinical Decision-Making12/16/2024 10:15 AM Palbociclib–Endocrine Therapy Combo Outperforms Standard Chemotherapy in HR+/HER2− Metastatic Breast Cancer12/16/2024 4:24 AM Imlunestrant Shows PFS Benefit in Advanced Breast Cancer12/13/2024 6:16 AM Doing the Best They Can11/14/2024 2:20 PM Starting Mammograms at Age 40: Will Women Benefit?10/29/2024 9:36 AM FDA Approves Inavolisib for HR+, HER2−, Advanced Breast Cancer With PIK3CA Mutation10/11/2024 2:44 AM By the Numbers: Monthly Treatment Cost Not Tied to Survival in Breast Cancer9/26/2024 7:31 AM Mental Health Considerations in Metastatic Breast Cancer: 5 Things to Know9/18/2024 9:20 AM Most Oncology Patients Interested in Discussing Flexible Dosing9/18/2024 9:18 AM Trastuzumab Deruxtecan Shows Promise in HER2+ BC with Brain Metastases9/15/2024 12:42 PM Optimal Management of Side Effects Associated With PIK3CA and mTOR Inhibitors8/7/2024 10:31 AM BC Patients See Minimal Cognitive Decline with CDK4/68/1/2024 5:09 AM Black Women With Breast Cancer Face Clinical Inequities7/30/2024 3:20 AM Eribulin Effective When Paired With Dual HER2 Blockade in BC7/12/2024 2:52 AM PFS Benefits Seen With Palbociclib + Endocrine Therapy in BC7/11/2024 2:44 AM New Approaches in the Treatment of HR+ Metastatic Breast Cancer7/10/2024 8:07 AM New ADC Results Mixed in Metastatic Breast Cancer7/10/2024 3:50 AM
